Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study

Peer Review reports

Original Submission
10 Aug 2007	Submitted	Original manuscript
5 Nov 2007	Reviewed	Reviewer Report - Mark Freedman
5 Nov 2007	Reviewed	Reviewer Report - Robert Fox
15 Nov 2007	Reviewed	Reviewer Report - Carlo Pozzilli
Resubmission - Version 2
	Submitted	Manuscript version 2
3 Jan 2008	Reviewed	Reviewer Report - Robert Fox
4 Jan 2008	Reviewed	Reviewer Report - Carlo Pozzilli
20 Feb 2008	Author responded	Author comments - Anthony Traboulsee
Resubmission - Version 3
20 Feb 2008	Submitted	Manuscript version 3
11 Apr 2008	Author responded	Author comments - Anthony Traboulsee
Resubmission - Version 4
11 Apr 2008	Submitted	Manuscript version 4
Publishing
21 Apr 2008	Editorially accepted
21 Apr 2008	Article published	10.1186/1471-2377-8-11

Back to article page